Publications by authors named "Jonathan L Kaufman"

84Publications

Roundtable: How I treat a newly diagnosed patient with high-risk myeloma.

Hematology Am Soc Hematol Educ Program 2019 12;2019(1):120-124

Winship Cancer Institute, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/hematology.2019000015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913472PMC
December 2019

Registering a CD38 antibody upfront for multiple myeloma.

Lancet 2019 07 3;394(10192):3-4. Epub 2019 Jun 3.

Winship Cancer Institute of Emory University, Atlanta, GA 30307, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)31250-4DOI Listing
July 2019

Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients.

Cancer 2019 09 15;125(17):2991-3000. Epub 2019 May 15.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32178DOI Listing
September 2019

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.

Nat Commun 2019 04 23;10(1):1911. Epub 2019 Apr 23.

Department of Hematology and Medical Oncology, Emory University School of Medicine, 1365 Clifton Rd. NE, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-09555-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478743PMC
April 2019

Daratumumab in multiple myeloma.

Cancer 2019 07 5;125(14):2364-2382. Epub 2019 Apr 5.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32065DOI Listing
July 2019

Reply to African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies.

Cancer 2019 07 28;125(13):2322-2324. Epub 2019 Mar 28.

Winship Cancer Institute of Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32080DOI Listing
July 2019

Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma.

Leukemia 2019 05 24;33(5):1291-1296. Epub 2019 Jan 24.

Department of Hematology and Medical Oncology, Emory University School of Medicine and the Winship Cancer Institute of Emory University, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0374-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891824PMC
May 2019

Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.

Cancer 2019 02 17;125(3):416-423. Epub 2018 Oct 17.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31718
Publisher Site
http://dx.doi.org/10.1002/cncr.31718DOI Listing
February 2019

Response to therapeutic monoclonal antibodies for multiple myeloma in African Americans versus whites.

Cancer 2018 11 10;124(22):4358-4365. Epub 2018 Oct 10.

Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31746
Publisher Site
http://dx.doi.org/10.1002/cncr.31746DOI Listing
November 2018

Myocarditis With Radiotherapy and Immunotherapy in Multiple Myeloma.

J Oncol Pract 2018 09 13;14(9):561-564. Epub 2018 Jul 13.

Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00208DOI Listing
September 2018

Novel Approaches for the Management of AL Amyloidosis.

Curr Hematol Malig Rep 2018 06;13(3):212-219

Winship Cancer Institute, Emory University, 1365C Clifton Road, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-018-0450-1DOI Listing
June 2018

High-risk Multiple Myeloma: Definition and Management.

Clin Lymphoma Myeloma Leuk 2017 07;17S:S80-S87

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.02.018DOI Listing
July 2017

Insights Into the Appropriate Use of New Antimyeloma Therapies.

Oncology (Williston Park) 2017 01;31(1):64, 66

View Article

Download full-text PDF

Source
January 2017

Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myeloma.

Cancer Biol Ther 2016 07;17(7):769-77

b Department of Hematology and Medical Oncology , Winship Cancer Institute of Emory University , Atlanta , GA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384047.2016.1192086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970534PMC
July 2016

Predictors of survival outcomes in phase 1 relapsed or refractory multiple myeloma patients.

Cancer 2015 Mar 6;121(6):853-62. Epub 2014 Nov 6.

Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29136DOI Listing
March 2015

Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema.

Clin Lymphoma Myeloma Leuk 2014 Dec 21;14(6):e213-5. Epub 2014 Jun 21.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.06.018DOI Listing
December 2014

Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.

Clin Lymphoma Myeloma Leuk 2014 Apr 15;14(2):e59-63. Epub 2013 Nov 15.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650130047
Publisher Site
http://dx.doi.org/10.1016/j.clml.2013.11.007DOI Listing
April 2014

Non-secretory myeloma: a clinician's guide.

Oncology (Williston Park) 2013 Sep;27(9):924-8, 930

View Article

Download full-text PDF

Source
September 2013

Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials.

Cancer 2013 Dec 4;119(23):4119-28. Epub 2013 Sep 4.

Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28325DOI Listing
December 2013

Histone deacetylase inhibitors in multiple myeloma: rationale and evidence for their use in combination therapy.

Clin Lymphoma Myeloma Leuk 2013 Aug 17;13(4):370-6. Epub 2013 Jun 17.

Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.03.016DOI Listing
August 2013

Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma.

Biol Blood Marrow Transplant 2013 Sep 10;19(9):1393-5. Epub 2013 Jun 10.

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.06.003DOI Listing
September 2013

Bortezomib administration with severe hyperbilirubinemia caused by hepatic plasma cell infiltration: a case report.

Clin Lymphoma Myeloma Leuk 2013 Apr 17;13(2):159-61. Epub 2012 Oct 17.

Winship Cancer Institute of Emory University, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S215226501200165
Publisher Site
http://dx.doi.org/10.1016/j.clml.2012.09.005DOI Listing
April 2013

Toxicities of mobilized stem cell infusion.

Methods Mol Biol 2012 ;904:111-5

Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-61779-943-3_10
Publisher Site
http://dx.doi.org/10.1007/978-1-61779-943-3_10DOI Listing
December 2012

The era of combination therapy in myeloma.

J Clin Oncol 2012 Jul 14;30(20):2434-6. Epub 2012 May 14.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2011.40.6967
Publisher Site
http://dx.doi.org/10.1200/JCO.2011.40.6967DOI Listing
July 2012

Putting the E (evidence) in a new Era for myeloma.

Leuk Lymphoma 2011 Mar;52(3):349-50

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.557170DOI Listing
March 2011

Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up-regulation of death receptors.

Clin Cancer Res 2008 Aug;14(16):5090-8

Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0016DOI Listing
August 2008

Multiple myeloma presenting with advanced renal failure: a case report and new treatment options.

Clin Lymphoma Myeloma 2008 Feb;8(1):52-4

Atlanta Hematology & Onclogy Associates, PC, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2008.n.004DOI Listing
February 2008

Proteasome inhibition: novel therapy for multiple myeloma.

Onkologie 2006 Apr 29;29(4):162-8. Epub 2006 Mar 29.

Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000091692DOI Listing
April 2006

Novel treatment approaches for patients with multiple myeloma.

Clin Lymphoma Myeloma 2006 Jan;6(4):281-8

Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2006.n.002DOI Listing
January 2006

IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA.

J Immunol 2004 Feb;172(3):1699-710

Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.172.3.1699DOI Listing
February 2004